高雄醫學大學圖書館 |

Carbohydrate-based vaccines :from concept to clinic /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Carbohydrate-based vaccines :/ A. Krishna Prasad, editor.
其他題名:	from concept to clinic /
其他作者:	Prasad, A. Krishna,
面頁冊數:	1 online resource (409 pages) :illustrations (some color). :
附註:	Distributed in print by Oxford University Press.
標題:	MEDICAL / Immunology. -
電子資源:	https://pubs.acs.org/doi/book/10.1021/bk-2018-1290
ISBN:	9780841233294

Carbohydrate-based vaccines :from concept to clinic /
Carbohydrate-based vaccines :from concept to clinic /A. Krishna Prasad, editor. - 1 online resource (409 pages) :illustrations (some color). - ACS symposium series,12901947-5918 ;. - ACS symposium series ;1014..

Distributed in print by Oxford University Press.

Includes bibliographical references and index.

Introduction /Prasad, A. Krishna /http://dx.doi.org/10.1021/bk-2018-1290.ch001 --

ISBN: 9780841233294

Standard No.: bk-2018-1290Subjects--Topical Terms:

468701
MEDICAL / Immunology.

LC Class. No.: QR189 / .C37 2018

Dewey Class. No.: 615.3/72

National Library of Medicine Call No.: QW 805

Carbohydrate-based vaccines :from concept to clinic /
LDR:06882nam a2200337 i 4500 001 339731
006 m o d
007 cr cn ---unuuu
008 210625s2018 dcua ob 101 0 eng d
020 $a 9780841233294 $q electronic
024 8 $a bk-2018-1290
035 $a ccn00855668
040 $a NjRocCCS $b eng $e rda $c NjRocCCS
050 4 $a QR189 $b .C37 2018
060 4 $a QW 805
082 0 4 $a 615.3/72 $2 23
084 $a MED044000 $2 bisacsh
245 0 0 $a Carbohydrate-based vaccines : $b from concept to clinic / $c A. Krishna Prasad, editor.
264 1 $a Washington, DC : $b American Chemical Society, $c 2018.
300 $a 1 online resource (409 pages) : $b illustrations (some color).
336 $a text $2 rdacontent
337 $a computer $2 rdamedia
338 $a online resource $2 rdacarrier
490 1 $a ACS symposium series, $x 1947-5918 ; $v 1290
500 $a Distributed in print by Oxford University Press.
504 $a Includes bibliographical references and index.
505 0 0 $t Introduction / $r Prasad, A. Krishna / $u http://dx.doi.org/10.1021/bk-2018-1290.ch001 -- $t Glycoconjugate Vaccines: The Clinical Journey / $r Lockhart, Stephen P., Pfizer Vaccines Clinical Research and Development, Horizon Building, Honey Lane, Hurley SL6 6RJ, United Kingdom; Scott, Daniel A., Pfizer Vaccine Clinical Research and Development, 500 Arcola Rd., Collegeville, Pennsylvania 19426, United States; Jansen, Kathrin U., Pfizer Vaccines Research and Development, 401 N. Middletown Rd., Pearl River, New York 10965-1299, United States; Anderson, Annaliesa S., Pfizer Vaccines Research and Development, 401 N. Middletown Rd., Pearl River, New York 10965-1299, United States; Gruber, William C., Pfizer Vaccines Research and Development, 401 N. Middletown Rd., Pearl River, New York 10965-1299, United States / $u http://dx.doi.org/10.1021/bk-2018-1290.ch002 -- $t Immunological Mechanisms of Glycoconjugate Vaccines / $r Duke, Jeremy A.; Avci, Fikri Y. / $u http://dx.doi.org/10.1021/bk-2018-1290.ch003 -- $t Design and Development of Glycoconjugate Vaccines / $r Prasad, A. Krishna; Kim, Jin-hwan; Gu, Jianxin / $u http://dx.doi.org/10.1021/bk-2018-1290.ch004 -- $t Manufacturing Considerations for Glycoconjugate Vaccines / $r Prasad, A. Krishna, Pfizer Vaccines Research and Development, 401 N. Middletown Rd., Pearl River, New York 10965, United States; Murphy, Kent, Pfizer Global Supply, 4300 Oak Park, Sanford, North Carolina 27330, United States; Kolodziej, Stephen A., Pfizer Biotherapeutics and Pharmaceutical Sciences, 700 Chesterfiled Parkway W., Chesterfield, Missouri 63017, United States / $u http://dx.doi.org/10.1021/bk-2018-1290.ch005 -- $t Multivalent Meningococcal Conjugate Vaccines: Chemical Conjugation Strategies Used for the Preparation of Vaccines Licensed or in Clinical Trials / $r Berti, Francesco / $u http://dx.doi.org/10.1021/bk-2018-1290.ch006 -- $t The Role of Molecular Modeling in Predicting Carbohydrate Antigen Conformation and Understanding Vaccine Immunogenicity / $r Kuttel, Michelle M., Department of Computer Science, University of Cape Town, Private Bag X3, Rondebosch 7701, Cape Town, South Africa; Ravenscroft, Neil, Department of Computer Science, University of Cape Town, Private Bag X3, Rondebosch 7701, Cape Town, South Africa / $u http://dx.doi.org/10.1021/bk-2018-1290.ch007 -- $t Advances in Synthetic Approaches towards Glycoantigens / $r Vartak, A. R.; Sucheck, S. J. / $u http://dx.doi.org/10.1021/bk-2018-1290.ch008 -- $t Formulation Development of Glycoconjugate Vaccines for Low- and Middle-Income Countries / $r Khandke, Lakshmi; Welsch, Jo Anne; Alderson, Mark R. / $u http://dx.doi.org/10.1021/bk-2018-1290.ch009 -- $t Preclinical Assessment of Glycoconjugate Vaccines / $r Scully, Ingrid L.; Swanson, Kena A.; Kanevsky, Isis; Prasad, A. Krishna; Anderson, Annaliesa S. / $u http://dx.doi.org/10.1021/bk-2018-1290.ch010 -- $t Campylobacter jejuni Capsule Polysaccharide Conjugate Vaccine / $r Monteiro, Mario A., Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Noll, Alexander, Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910, United States; Laird, Renee M., Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910, United States; Pequegnat, Brittany, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Ma, Zuchao, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Bertolo, Lisa, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; DePass, Christina, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Omari, Eman, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Gabryelski, Pawel, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Redkyna, Olena, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Jiao, Yuening, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Borrelli, Silvia, Department of Chemistry, University of Guelph, Guelph, Ontario N1G 2W1, Canada; Poly, Frederic, Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910, United States; Guerry, Patricia, Enteric Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 20910, United States / $u http://dx.doi.org/10.1021/bk-2018-1290.ch011 -- $t Chemistry Manufacturing, Control, and Licensure for Carbohydrate-Based Vaccines / $r Jones, Christopher / $u http://dx.doi.org/10.1021/bk-2018-1290.ch012 -- $t Lessons Learned and Future Challenges in the Design and Manufacture of Glycoconjugate Vaccines / $r Hennessey, John P., Consultant, Lower Gwynedd, Pennsylvania 19002, United States; Costantino, Paolo, GSK, Siena 53100, Italy; Talaga, Philippe, Department of Analytical Research and Development, Sanofi Pasteur, Marcy l’Etoile 69280, France; Beurret, Michel, Janssen Vaccines & Prevention B.V., Leiden, 2301 CA, The Netherlands; Ravenscroft, Neil, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa; Alderson, Mark R., PATH, Seattle, Washington 98121, United States; Zablackis, Earl, Analytical Process Technology, Sanofi Pasteur, Swiftwater, Pennsylvania 18370, United States; Prasad, A. Krishna, Pfizer Vaccines Research and Development, Pearl River, New York 10965, United States; Frasch, Carl, Consultant, Martinsburg, West Virginia 25402, United States / $u http://dx.doi.org/10.1021/bk-2018-1290.ch013 -- $t Editor’s Biography / $u http://dx.doi.org/10.1021/bk-2018-1290.ot001
588 $a Description based on publisher-supplied information and home-page.
590 $a American Chemical Society, ACS Symposium Series eBooks - 2018 Front Files.
650 7 $a MEDICAL / Immunology. $2 bisacsh $3 468701
650 2 2 $a Carbohydrates $x immunology. $3 468700
650 0 $a Glycoconjugates $x Therapeutic use $x Forecasting. $3 468699
650 0 $a Carbohydrate drugs $x Licenses. $3 468698
650 0 $a Carbohydrate drugs $x Industrial applications. $3 468697
650 0 $a Polysaccharides $x Immunology. $3 468696
650 0 $a Glycoconjugates $x Therapeutic use $z Developing countries. $3 468695
650 0 $a Glycomics $x Therapeutic use. $3 468694
650 0 $a Immunogenetics. $3 468693
650 0 $a Antigens $x Molecular aspects $x Models. $3 468692
650 0 $a Clinical medicine $x Research. $3 468691
650 0 $2 96060 $a Clinical trials. $3 213847
650 0 $a Antibody-drug conjugates. $3 468690
650 0 $a Bioconjugates $x Immunology. $3 468689
650 0 $a Meningococcal infections $x Chemotherapy. $3 468688
650 0 $a Carbohydrate drugs $x Design and construction. $3 468687
650 0 $a Glycoconjugates $x Design and construction. $3 468686
650 0 $a Glycoconjugates $x Immunology. $3 468685
650 0 $a Glycoconjugates $x Therapeutic use. $3 468684
650 0 $a Carbohydrates $x Therapeutic use. $3 468683
650 0 $a Carbohydrates $x Immunology. $3 468682
650 0 $a Glycoconjugates. $3 468681
650 0 $2 96060 $a Vaccines. $3 244611
700 1 $a Prasad, A. Krishna, $e editor. $u Pfizer Vaccines Research and Development, Pearl River, New York. $3 468678
710 2 $a American Chemical Society. $b Cellulose and Renewable Materials Division, $e sponsoring body. $3 468680
710 2 $a American Chemical Society. $b Division of Carbohydrate Chemistry, $e sponsoring body. $3 468679
776 1 $c Original $z 9780841233379 (alk. paper)
776 1 $c Online version $w (OCoLC)1044776964
830 0 $a ACS symposium series ; $v 1014. $3 311094
856 4 $3 ACS $u https://pubs.acs.org/doi/book/10.1021/bk-2018-1290